pH-Responsive Hydrogels with Dispersed Hydrophobic Nanoparticles for the Delivery of Hydrophobic Therapeutic Agents - Wikidata - wikimedia - TriplyDB

pH-Responsive Hydrogels with Dispersed Hydrophobic Nanoparticles for the Delivery of Hydrophobic Therapeutic Agents

pH-Responsive Hydrogels with Dispersed Hydrophobic Nanoparticles for the Delivery of Hydrophobic Therapeutic Agents

http://www.wikidata.org/entity/Q36327202

about

25th anniversary article: Rational design and applications of hydrogels in regenerative medicine A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics Intelligent recognitive systems in nanomedicine.Current progress in Reactive Oxygen Species (ROS)-Responsive materials for biomedical applications.Advances in Functional Assemblies for Regenerative Medicine.Hybrid responsive hydrogel carriers for oral delivery of low molecular weight therapeutic agents.pH-responsive hydrogels with dispersed hydrophobic nanoparticles for the oral delivery of chemotherapeutics.pH-responsive hydrogels containing PMMA nanoparticles: an analysis of controlled release of a chemotherapeutic conjugate and transport properties.Personalizing Biomaterials for Precision Nanomedicine Considering the Local Tissue Microenvironment.Nanostructured DPA-MPC-DPA triblock copolymer gel for controlled drug release of ketoprofen and spironolactone.ROS-cleavable proline oligomer crosslinking of polycaprolactone for pro-angiogenic host response Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications.Hydrogels with smart systems for delivery of hydrophobic drugs.Achieving High Drug Loading and Sustained Release of Hydrophobic Drugs in Hydrogels through In Situ Crystallization.Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery.pH-Responsive polymers Smart Hydrogels: Therapeutic Advancements in Hydrogel Technology for Smart Drug Delivery Applications A novel pH-sensitive ceramic-hydrogel for biomedical applications Bioactive composites fabricated by freezing-thawing method for bone regeneration applications Poly(methacrylic acid)-l-Polyisobutylene Amphiphilic Conetworks by Using an Ethoxyethyl-Protected Comonomer: Synthesis, Protecting Group Removal in the Cross-Linked State, and Characterization

P2860

Q26827960-FC85F272-1631-4226-9E62-413A2FE87115 Q27006569-278EDE3A-C35B-4A84-B725-0FE1F3302EFD Q33632768-7E75A6E3-A791-4A04-A06C-FA4046500F9A Q34097227-50382386-0673-423A-BF2E-9CA49026AA05 Q35894382-F0D79EA2-E891-4D61-AF47-1ADDA3A43CBA Q36376449-12D9C741-8F01-40F1-A763-C02704172938 Q36746601-67FE0DEB-AE17-4ADE-B9C7-6F9802B2EF96 Q36870775-8E5A6B2A-4156-4FC2-A703-D44D1E473484 Q38473948-7662B85E-E45D-4BF0-AD6E-AA3AE58BB0B5 Q38798931-DB830015-35EB-4E47-86A9-E1514C37C338 Q42548783-4B4E853D-3B75-4F83-9B9A-BFA4AF6097E9 Q48174596-50BB4A76-11EC-438F-9DE4-86A8D9891C65 Q48319795-A7FE060C-8565-4300-8E39-06EE7B605216 Q50750308-94C47515-F100-418D-8505-AB60B48A8D05 Q55223335-CBF477F3-A3F6-4FF5-8B4B-98CDD3DB45E1 Q56225480-40EE43AD-FF59-4CF2-A47C-B2395540AF76 Q57340525-70FA5391-EF06-4F31-B3DC-6B2CFBA82827 Q57344210-14B69610-2F8D-4D2D-8CBA-FAFA8198CED8 Q57345079-7B938D4E-0BD3-41A0-ACD5-11C62239F4EF Q57349688-2CEE3B03-6804-490E-B968-A8A825A4262B

P2860

pH-Responsive Hydrogels with Dispersed Hydrophobic Nanoparticles for the Delivery of Hydrophobic Therapeutic Agents

http://www.wikidata.org/entity/Q36327202

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

pH-Responsive Hydrogels with D ...... Hydrophobic Therapeutic Agents

@ast

pH-Responsive Hydrogels with D ...... Hydrophobic Therapeutic Agents

@en

type

label

pH-Responsive Hydrogels with D ...... Hydrophobic Therapeutic Agents

@ast

pH-Responsive Hydrogels with D ...... Hydrophobic Therapeutic Agents

@en

prefLabel

pH-Responsive Hydrogels with D ...... Hydrophobic Therapeutic Agents

@ast

pH-Responsive Hydrogels with D ...... Hydrophobic Therapeutic Agents

@en

P1433

Q36327202-8C86CA74-EAD3-4C04-B056-7493093AEC50

P1476

Q36327202-D7625BE3-C373-43DF-AFC2-130381340BAE

P2093

Q36327202-3A695D12-DD22-46C2-8D6F-D9715E2F84C3

Q36327202-72F4FB01-B13E-4F26-9680-8123B06F62A0

Q36327202-CFB1F0E4-AAF0-4D22-B0D5-1B5E126EE7CA

P2860

Q36327202-0307B304-9C41-4C0D-8E11-E3E02B7ABFF7

Q36327202-07DEF7CF-E152-40B4-A8F1-8633DF4C6D6F

Q36327202-103404A1-2201-4A2A-888F-557B9FCE601B

Q36327202-10460857-0227-466A-9118-E3525D84443E

Q36327202-10BD5B48-296F-453D-A52F-519EF3F55C8E

Q36327202-1AC5F296-E5EF-4AFC-8CAF-F222123F68C7

Q36327202-1F774C83-8681-4BA7-88FF-FB839BEC631F

Q36327202-362A915E-8356-47EC-A415-6A742EA3E74A

Q36327202-4049B1A6-D77C-4466-936D-1091499536D7

Q36327202-433081DC-1D8A-41B7-A7FB-CEB1B591E19C

P304

Q36327202-77DF93B9-BF79-467A-B59C-C6D47796F6E6

P31

Q36327202-86844ADD-F3DC-4DAA-A73C-851F395612DF

P356

Q36327202-BE643DFB-7304-4B54-9DCA-AA1700A30D48

P433

Q36327202-12C195A8-E0A0-4503-8F3E-EA2C7C0120F9

P478

Q36327202-0683C574-B03D-4BA8-821F-A581BBE9719C

P577

Q36327202-95881ECF-DFF0-46A8-9FFB-3F9F941EFC87

P5875

Q36327202-479A948D-02A7-4641-893C-1A2E6B9D529A

P698

Q36327202-4F994D0F-2DAB-42C4-B8C9-388F32357B62

P921

Q36327202-0F2ACCC0-D6E2-4DFC-AE38-083FCECCA41E

Q36327202-A7E708F0-DE1E-4008-85B2-DE888255945D

Q36327202-C2CBA8EB-7CCD-4813-B2F8-63A6468FBC2C

P932

Q36327202-9440C710-EE1F-4EC7-9857-C1260A878D59

P356

P1433

Polymer International

P1476

pH-Responsive Hydrogels with D ...... Hydrophobic Therapeutic Agents

@en

P2093

Cody A Schoener

http://www.w3.org/2001/XMLSchema#string

Heather N Hutson

http://www.w3.org/2001/XMLSchema#string

Nicholas A Peppas

http://www.w3.org/2001/XMLSchema#string

P2860

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Photo-cross-linked PDMSstar-PEG hydrogels: synthesis, characterization, and potential application for tissue engineering scaffolds.

Hydrogels in pharmaceutical formulations.

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

Complexation Hydrogels for the Oral Delivery of Growth Hormone and Salmon Calcitonin

Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.

Genomic approaches to identification of tumour-susceptibility genes using mouse models.

Sustained release of VEGF from PLGA nanoparticles embedded thermo-sensitive hydrogel in full-thickness porcine bladder acellular matrix.

Amphiphilic Interpenetrating Networks for the Delivery of Hydrophobic, Low Molecular Weight Therapeutic Agents.

P304

874-879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PI.4219

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232535990

http://www.w3.org/2001/XMLSchema#string

P698

23087546

http://www.w3.org/2001/XMLSchema#string

P921

P932

3474376

http://www.w3.org/2001/XMLSchema#string